Search Results - Planchce, L.

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    S176: DARATUMUMAB CARFILZOMIB LENALIDOMIDE AND DEXAMETHASONE AS INDUCTION THERAPY IN HIGH‐RISK TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MYELOMA PATIENTS: RESULTS OF THE PHASE 2 STUDY IFM 2018‐04

    S176: DARATUMUMAB CARFILZOMIB LENALIDOMIDE AND DEXAMETHASONE AS INDUCTION THERAPY IN HIGH‐RISK TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MYELOMA PATIENTS: RESULTS OF THE PHASE 2 STUDY IF... by Touzeau, C., Perrrot, A., Hulin, C., Manier, S., Macro, M., Chretien, M.‐L., Karlin, L., Decaux, O., Jacquet, C., Tiab, M., Leleu, X., Planchce, L., Avet‐Loiseau, H., Moreau, P.

    Published in HemaSphere
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: